Acute bronchial asthma

Main Article Content

Susanna Ramuscello *
Valeria Tombini
Emanuela Perucchini
Daniele Coen
(*) Corresponding Author:
Susanna Ramuscello | lucia.zoppi@pagepress.org

Abstract

Asthma is one of the main causes of morbidity worldwide. It affects some 300 million individuals and has risen over the past 20 years, especially in the paediatric population. Asthma is a chronic inflammation of the airways, subject to periodic exacerbations, characterised by coughing and progressive dyspnoea. Clinical conditions may vary greatly, ranging from moderate exacerbation with an increase in nocturnal awakening and a less than 20% reduction in the flow peak, through to severe respiratory insufficiency that requires immediate intubation of the airways. Pharmacological treatment envisages a step approach that aims to obtain and maintain control over the symptoms, taking into consideration the effectiveness of the treatment available, potential side effects and cost. β2-agonists and corticosteroids are the drugs of election for both maintenance therapy and for treating exacerbations. Other therapeutic devices may prove useful in particular cases. One fundamental key point in treatment over time is the cooperation between patient and attending doctor. The latest review of the Global Initiative for Asthma (GINA) guidelines was published in 2006.

Downloads month by month

Downloads

Download data is not yet available.

Article Details

Author Biographies

Susanna Ramuscello, Medicina d’Urgenza e Pronto Soccorso, Ospedale Niguarda Ca’ Granda, Milano

Valeria Tombini, Medicina d’Urgenza e Pronto Soccorso, Ospedale Niguarda Ca’ Granda, Milano

Emanuela Perucchini, Medicina d’Urgenza e Pronto Soccorso, Ospedale Niguarda Ca’ Granda, Milano

Daniele Coen, Medicina d’Urgenza e Pronto Soccorso, Ospedale Niguarda Ca’ Granda, Milano